XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 8,556 $ 8,096
Short-term investments 372 0
Accounts receivable (net of allowance for doubtful accounts of $95 in 2022 and $62 in 2021) 9,828 9,230
Inventories (excludes inventories of $2,495 in 2022 and $2,194 in 2021 classified in Other assets - see Note 7) 5,774 5,953
Other current assets 6,654 6,987
Total current assets 31,184 30,266
Investments 316 370
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,498 in 2022 and $18,192 in 2021 19,747 19,279
Goodwill 21,258 21,264
Other Intangibles, Net 23,022 22,933
Other Assets 11,141 11,582
Total Assets 106,668 105,694
Current Liabilities    
Loans payable and current portion of long-term debt 1,208 2,412
Trade accounts payable 3,715 4,609
Accrued and other current liabilities 14,051 13,859
Income taxes payable 1,571 1,224
Dividends payable 1,771 1,768
Total current liabilities 22,316 23,872
Long-Term Debt 30,586 30,690
Deferred Income Taxes 3,071 3,441
Other Noncurrent Liabilities 9,742 9,434
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021 1,788 1,788
Other paid-in capital 44,275 44,238
Retained earnings 56,252 53,696
Accumulated other comprehensive loss (4,369) (4,429)
Stockholders' equity before deduction for treasury stock 97,946 95,293
Less treasury stock, at cost: 1,048,727,225 shares in 2022 and 1,049,499,023 shares in 2021 57,063 57,109
Total Merck & Co., Inc. stockholders’ equity 40,883 38,184
Noncontrolling Interests 70 73
Total equity 40,953 38,257
Liabilities and Equity $ 106,668 $ 105,694